← ANALYST RATINGS · TIPRANKS

Hims & Hers Health (HIMS): analyst forecast and price target

$28.07 −4.46% close 16.10.26 · market cap $6.9B · Healthcare · Medical - Care Facilities IWM 0.21%
Price targets and ratings of

Analyst consensus

Hold

3 Buy11 Hold0 Sell

Ratings of 14 analysts in the last 3 months

12-month forecast

$32.82+16.9% upside

Based on 14 price targets given in the last 3 months, the average target is $32.82, the highest $42.00, the lowest $26.00. The average is +16.9% from the last price of $28.07.

$20.00$40.00$60.00Jan 26AprJulOctJan 27AprJulOctHigh$42.00Average$32.82Low$26.00
Highest target $42.00 Average target $32.82 Lowest target $26.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $32.00 Hold +14.0% Reiterated 15.10.26on TipRanks Oct 16 04:55 +5.7%next day −3.4%
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $32.00 Hold +14.0% Reiterated 08.10.26on TipRanks Oct 9 04:55 −4.6%next day +9.6% · 5 days +5.0%
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $32.00 Hold +14.0% Reiterated 25.09.26on TipRanks 06:10 −0.1%next day −1.4% · 5 days −1.2%
Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% Truist Financial $32.00 Hold +14.0% Reiterated 11.09.26on TipRanks 07:50 −0.6%next day +5.2% · 5 days +1.8%
Bryan Smilek★★★★★★★★★★#11852 · hits 39% · avg −12.4% J.P. Morgan $32.00 Hold +14.0% Initiated 11.09.26on TipRanks 06:15 −0.6%next day +5.2% · 5 days +1.8%
Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% Jefferies $31.00 Hold +10.4% Reiterated 03.09.26on TipRanks 09:10 −4.0%next day 0.0% · 5 days 0.0%
Justin Patterson★★★★★★★★★★#1977 · hits 46% · avg +6.3% KeyBanc — Hold — Reiterated 02.09.26on TipRanks 05:05 +0.4%next day −4.0% · 5 days −3.4%
Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% Barclays $39.00 → $35.00−10.3% Buy +24.7% Reiterated 20.08.26on TipRanks Aug 21 04:26 +3.3%next day +5.6% · 5 days −1.7%
Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% Citi $35.00 → $33.00−5.7% Hold +17.6% Reiterated 12.08.26on TipRanks Aug 11 06:35 −3.6%next day −2.0% · 5 days −9.8%
George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% Deutsche Bank $25.00 → $26.00+4.0% Hold −7.4% Assigned 11.08.26on TipRanks 08:50 −3.6%next day −2.0% · 5 days −9.8%
Jonna Kim★★★★★★★★★★#3164 · hits 49% · avg +10.0% TD Cowen $25.00 → $30.00+20.0% Hold +6.9% Assigned 11.08.26on TipRanks 07:50 −3.6%next day −2.0% · 5 days −9.8%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $21.00 → $28.00+33.3% Hold −0.2% Assigned 11.08.26on TipRanks 07:15 −3.6%next day −2.0% · 5 days −9.8%
Maria Ripps★★★★★★★★★★#497 · hits 48% · avg +18.0% Canaccord Genuity $40.00 Buy +42.5% Reiterated 11.08.26on TipRanks 07:05 −3.6%next day −2.0% · 5 days −9.8%
Ryan MacDonald★★★★★★★★★★#12366 · hits 37% · avg −11.1% Needham $35.00 → $42.00+20.0% Buy +49.6% Reiterated 11.08.26on TipRanks 07:01 −3.6%next day −2.0% · 5 days −9.8%
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG — Hold — Assigned 11.08.26on TipRanks 06:55 −3.6%next day −2.0% · 5 days −9.8%
Mark Mahaney★★★★★★★★★★#639 · hits 55% · avg +12.1% Evercore ISI — Hold — Reiterated 11.08.26on TipRanks Aug 10 22:05 −3.6%next day −2.0% · 5 days −9.8%
Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% Leerink Partners — Hold — Reiterated 16.04.26on TipRanks 09:55 +10.9%next day +5.6% · 5 days +3.3%
Unknown Analyst Nephron $35.00 Buy +24.7% Upgrade 09.03.26on TipRanks 11:35 +39.9%next day +6.1% · 5 days +13.6%
Unknown Analyst Mizuho Securities $30.00 Sell +6.9% Reiterated 18.11.25on TipRanks 10:00 +2.8%next day −1.6% · 5 days 0.0%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Hims & Hers Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Maria Ripps★★★★★★★★★★Canaccord Genuity · #497
Hits 48%221 of 457 Average return +18.0%
1 year Glen Santangelo★★★★★★★★★★Barclays · #2956
Hits 52%174 of 336 Average return +4.5%
2 years Glen Santangelo★★★★★★★★★★Barclays · #2956
Hits 52%174 of 336 Average return +4.5%

Most profitable

3 months Maria Ripps★★★★★★★★★★Canaccord Genuity · #497
Hits 48%221 of 457 Average return +18.0%
1 year Maria Ripps★★★★★★★★★★Canaccord Genuity · #497
Hits 48%221 of 457 Average return +18.0%
2 years Glen Santangelo★★★★★★★★★★Barclays · #2956
Hits 52%174 of 336 Average return +4.5%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $32.82 at a price of $29.79 (+10.2%); now: $32.82 at $28.07 (+16.9%).

$28.00$30.00$32.00Sep 15Oct 1Oct 15Top analysts$31.71Average target$32.82Price$28.07

PriceAverage targetTop analysts’ target

Recommendation trend

02040221413Oct 25211418Nov111315Dec111213Jan 26612012Feb74319Mar75366Apr11032May821Jun1025Jul922Aug727Sep417Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy100000
Buy10810974
Hold322125222717
Sell000000

Earnings and sales forecast

Next report: 09.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.06 (from $-0.05 to $0.20). Last quarter: $-0.37.

Sales

Next quarter’s sales estimate — $893M (from $884M to $902M). Last quarter: $753M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Hims & Hers Health
  • CEO: Andrew Dudum
  • Employees: 2,442
  • 2269 Chestnut Street, San Francisco, CA, 94123, US
  • www.hims.com

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Data from the stock’s TipRanks forecast page, read 6 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗